CGEN - Compugen Ltd
IEX Last Trade
2.1
0.070 3.333%
Share volume: 165,301
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.03
0.07
3.45%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | |
| Report Date | 2022-05-16 | 2022-08-04 | |
| Total revenue | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | |
| nan% | |||
| Operating expenses | 9.996 M | 9.637 M | |
| Selling general and admin | 2.826 M | 2.825 M | |
| Research and development | 7.170 M | 6.812 M | |
| Total expenses | 9.996 M | 9.637 M | |
| -3.59% | |||
| Operating income | -9.996 M | -9.637 M | |
| Ebit | -9.996 M | -9.637 M | |
| Pretax income | -9.710 M | -9.144 M | |
| -5.83% | |||
| Income tax | 0.000 | 0.000 | |
| Net income basic | -9.710 M | -9.144 M | |
| 5.83% | |||
| Net income | -9.710 M | -9.144 M | |
| 5.83% |